Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
EC/CAS
500-019-9/9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
*Chemical name, CAS number and/or exact concentration have be...
General Information
Version
2.1
Revision date
2019-01-11
Product name
Trastuzumab deruxtecan for Injection 100mg
1.2.1 Relevant identified uses
For clinical and / or commercial
Emergency telephone
+81-3-6225-1111
Icons in SDS
Company Information
company name
DAIICHI SANKYO CO., LTD Process Technology Group
Section 2
SECTION 2: Hazards identification
· Classification according to Regulation (EC) No 1272/2008 Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No information available
2.2 Label elements
There is no labelling obligation for this product.
Other hazards which do not result in classification
No information available. A certain % of the mixture consists of ingredient of unknown acute toxicity.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP]Mixtures: SDS < 2015 : Show CLP information only Classification not possible Adverse physicochemical, human health and environmental effects No information available.
